Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies.
Hosono Y, Sie B, Pinal-Fernandez I, Pak K, Mecoli CA, Casal-Dominguez M, Warner BM, Kaplan MJ, Albayda J, Danoff S, Lloyd TE, Paik JJ, Tiniakou E, Aggarwal R, Oddis CV, Moghadam-Kia S, Carmona-Rivera C, Milisenda JC, Grau-Junyent JM, Selva-O'Callaghan A, Christopher-Stine L, Larman HB, Mammen AL. Hosono Y, et al. Ann Rheum Dis. 2023 Feb;82(2):246-252. doi: 10.1136/ard-2022-222441. Epub 2022 Aug 25. Ann Rheum Dis. 2023. PMID: 36008132 Free PMC article.
Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis.
Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovský J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K. Kochi Y, et al. Among authors: hosono y. Ann Rheum Dis. 2018 Apr;77(4):602-611. doi: 10.1136/annrheumdis-2017-212149. Epub 2018 Jan 13. Ann Rheum Dis. 2018. PMID: 29331962
More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies.
Pinal-Fernandez I, Mecoli CA, Casal-Dominguez M, Pak K, Hosono Y, Huapaya J, Huang W, Albayda J, Tiniakou E, Paik JJ, Johnson C, Danoff SK, Corse AM, Christopher-Stine L, Mammen AL. Pinal-Fernandez I, et al. Among authors: hosono y. Neurology. 2019 Nov 5;93(19):e1768-e1777. doi: 10.1212/WNL.0000000000008443. Epub 2019 Oct 8. Neurology. 2019. PMID: 31594859 Free PMC article.
Validation of anti-Mi2 autoantibody testing by line blot.
Pinal-Fernandez I, Pak K, Casal-Dominguez M, Hosono Y, Mecoli C, Christopher-Stine L, Mammen AL. Pinal-Fernandez I, et al. Among authors: hosono y. Autoimmun Rev. 2020 Jan;19(1):102425. doi: 10.1016/j.autrev.2019.102425. Epub 2019 Nov 14. Autoimmun Rev. 2020. PMID: 31734399 No abstract available.
Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies.
Seto N, Torres-Ruiz JJ, Carmona-Rivera C, Pinal-Fernandez I, Pak K, Purmalek MM, Hosono Y, Fernandes-Cerqueira C, Gowda P, Arnett N, Gorbach A, Benveniste O, Gómez-Martín D, Selva-O'Callaghan A, Milisenda JC, Grau-Junyent JM, Christopher-Stine L, Miller FW, Lundberg IE, Kahlenberg JM, Schiffenbauer AI, Mammen A, Rider LG, Kaplan MJ. Seto N, et al. Among authors: hosono y. JCI Insight. 2020 Feb 13;5(3):e134189. doi: 10.1172/jci.insight.134189. JCI Insight. 2020. PMID: 31945019 Free PMC article.
The indirect immunofluorescence assay autoantibody profiles of myositis patients without known myositis-specific autoantibodies.
Casal-Dominguez M, Pinal-Fernandez I, Pak K, Marin-Sanchez A, Sanz-Martinez MT, Baucells A, Hosono Y, Christopher-Stine L, Mammen AL; Johns Hopkins Myositis Center Group. Casal-Dominguez M, et al. Among authors: hosono y. Clin Exp Rheumatol. 2021 May-Jun;39(3):519-524. doi: 10.55563/clinexprheumatol/7kyr5e. Epub 2020 Sep 3. Clin Exp Rheumatol. 2021. PMID: 32896249
[Reliability and clinical utility of Enzyme-linked immunosorbent assay for detection of anti-aminoacyl-tRNA synthetase antibody].
Abe T, Tsunoda S, Nishioka A, Azuma K, Tsuboi K, Ogita C, Yokoyama Y, Furukawa T, Maruoka M, Tamura M, Yoshikawa T, Saito A, Sekiguchi M, Azuma N, Kitano M, Matsui K, Hosono Y, Nakashima R, Ohmura K, Mimori T, Sano H. Abe T, et al. Among authors: hosono y. Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(2):140-4. doi: 10.2177/jsci.39.140. Nihon Rinsho Meneki Gakkai Kaishi. 2016. PMID: 27212600 Free article. Japanese.
Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.
Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, Hirata S, Nojima T, Sugiyama E, Hatta K, Taguchi Y, Katayama M, Tanizawa K, Handa T, Uozumi R, Akizuki S, Murakami K, Hashimoto M, Tanaka M, Ohmura K, Mimori T. Tsuji H, et al. Among authors: hosono y. Arthritis Rheumatol. 2020 Mar;72(3):488-498. doi: 10.1002/art.41105. Epub 2020 Jan 27. Arthritis Rheumatol. 2020. PMID: 31524333
Early initiation of plasma exchange therapy for a patient with anti-MDA5 autoantibody-positive dermatomyositis developing rapidly progressive interstitial lung disease.
Sasaki N, Ishii A, Kurabayashi T, Sugiyama M, Izumi Y, Nakagome Y, Hirano K, Sasaki S, Kondo Y, Nogi S, Nishikawa A, Hosono Y, Yamada C, Sato S. Sasaki N, et al. Among authors: hosono y. Mod Rheumatol Case Rep. 2021 Jan;5(1):87-94. doi: 10.1080/24725625.2020.1826641. Epub 2020 Oct 14. Mod Rheumatol Case Rep. 2021. PMID: 33048020
159 results